Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130468
Status:
COMPLETED
Last Update Posted:
2008-04-03
First Post:
2005-08-12
Brief Title:
TREAD-20 Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
A Double Blind Randomized Trial of Intra-Articular Injections of 20 mg of Hyalgan for the Treatment of Knee Pain Due to Osteoarthritis Three Injection-Regimen for Efficacy And Duration-20 mg2mL Dose Tread-20
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the efficacy and safety of intra-articular injections of 20 mg2mL dose HYALGAN in patients with pain due to osteoarthritis OA of the knee
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None